Background: Venom-induced consumption coagulopathy (VICC) from tiger snake (Notechis scutatus) envenomation results in a dose-dependent coagulopathy that is detectable on coagulometry. However, individual coagulation factor activities in dogs with tiger snake envenomation have not been determined. This study aimed to characterise VICC and the time course of recovery in tiger snake envenomed dogs and to investigate an association between tiger snake venom (TSV) concentrations and factor activity.
Methods: This was a prospective, observational, cohort study. The study cohort was 11 dogs of any age, breed, sex, body weight >10 kg, confirmed serum TSV on ELISA and treated with antivenom. Blood was collected at enrolment before antivenom administration, then at 3, 12 and 24 h after antivenom administration. Tiger snake venom concentrations were detected with a sandwich ELISA. Fibrinogen was measured using a modified Clauss method, and coagulation factors (F) II, V, VII, VIII and X were measured with factor-deficient human plasma using a modified prothrombin (PT) and activated partial thromboplastin (aPTT) method. Linear mixed models, with multiple imputations of censored observations, were used to determine the effect of time and TSV concentration on the coagulation times and factor activity. This cohort was compared to 20 healthy controls.
Results: At enrolment, there were severe deficiencies in fibrinogen, FV and FVIII, with predicted recovery by 10.86, 11.75 and 13.14 h after antivenom, respectively. There were modest deficiencies in FX and FII, with predicted recovery by 20.57 and 32.49 h after antivenom, respectively. No changes were detected in FVII. Prothrombin time and aPTT were markedly prolonged with predicted recovery of aPTT by 12.58 h. Higher serum TSV concentrations were associated with greater deficiencies in FII, FV and FVIII, and greater prolongations in coagulation times. The median (range) serum TSV concentration was 57 (6-2295) ng/mL.
Conclusions: In tiger snake envenomed dogs, we detected a profound, TSV-concentration-related consumption of select coagulation factors, that rapidly recovered toward normal. These findings allowed further insight into tiger snake VICC in dogs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.toxicon.2020.03.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Real world delays in antivenom administration: patient, snake or hospital factors (ASP-33).
Clin Toxicol (Phila)
December 2024
Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia.
Objective: Early antivenom administration is essential for effective treatment. We investigated the delays in antivenom administration.
Methods: We reviewed snakebites from the Australian Snakebite Project (2006-2021) given antivenom, presenting to hospital within 12 h.
Taipan envenoming … south of the border.
Anaesth Intensive Care
September 2024
Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia.
Article Synopsis
- - A 68-year-old man in northern New South Wales experienced severe complications from a taipan snakebite, including neurotoxicity, kidney injury, and blood clotting issues.
- - He required intubation and ventilation, along with dialysis for acute kidney injury, after being treated with antivenom for brown and tiger snakes.
- - Due to the confirmed presence of taipan venom in his system and the likelihood of future incidents, the study suggests that polyvalent antivenom should be readily available in the region.
Homing of translocated native Indian pythons in Moyar River Valley, South India.
Heliyon
July 2024
Forest Department, Government of Tamil Nadu, India, 600015.
Homing is often a critical aspect of an animal's behavioural and spatial ecology. Translocation is considered to be a wildlife management strategy that could reduce human-wildlife confrontation, but this strategy may not be effective if animals attempt to home to their original capture location. Translocation of animals from sites where possible human-wildlife interaction occurs is a widespread but controversial intervention to resolve conflicts.
View Article and Find Full Text PDFImmunoreactivity of eastern small eyed snake (Cryptophis nigrescens) venom towards species-specific antibodies of five medically important venomous Australian elapids.
Aust Vet J
September 2024
Padula Serums Pty Ltd, Bairnsdale, Victoria, 3875, Australia.
The eastern small eyed snake (Cryptophis nigrescens; CN) is an uncommon cause of snakebite in Australia despite the widespread distribution of the snake along the east coast of Australia. Diagnosis of envenomation relies on identification of the snake which is often not possible with animal snakebite cases. This study examined the immunoreactivity profile of CN venom towards specific rabbit IgG made against the medically relevant snake venom immunotypes found in Australia (tiger, brown, black, death adder and taipan).
View Article and Find Full Text PDFAnticoagulant activity in Australasian elapid snake venoms and neutralisation with antivenom and varespladib.
Toxicon
August 2024
Clinical Toxicology Research Group, University of Newcastle, New South Wales, Australia; Department of Clinical Toxicology, Calvary Mater Newcastle, New South Wales, Australia. Electronic address:
The venoms of Australasian elapid snakes are known to possess coagulant activity, including some with strong procoagulant activity and others with anticoagulant activity, although the latter are less well known. This study investigates the anticoagulant activity of Australasian elapid snake venoms, and whether this activity is neutralised by commercial snake antivenom and varespladib (PLA inhibiting agent). Clotting assays were completed for 34 species of Australasian elapids.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!